Quite rightly, patients will often turn to their GP for advice when making this decision.
Given that 11-18% of men with prostate cancer demonstrate decisional regret over their treatment choice1 it is vitally important that men take the time they need to make the decision that is correct for them. So how should GPs advise them?
In this opinion piece, I will briefly outline the way I view each option as it applies to patients who are fit for active treatment, have organ-confined disease, and are otherwise not suitable for active surveillance.